Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 24.16 is 28% above its 5-year average of 18.81, near the high end of its 5-year range (12.25–24.16).
39.86% above its 12-month average of 17.27.
Reported quarterly EPS; no daily interpolation.
EPS growth vs the same quarter one year earlier, last 40 quarters.
EARNINGS PER SHARE (EPS)
24.16
EARNINGS PER SHARE (EPS) AVG TTM
17.27
EARNINGS PER SHARE (EPS) AVG 3Y
18.45
EARNINGS PER SHARE (EPS) AVG 5Y
18.81
EARNINGS PER SHARE (EPS) AVG 10Y
14.71
EARNINGS PER SHARE (EPS) AVG 15Y
11.88
EARNINGS PER SHARE (EPS) AVG 20Y
9.88
CURRENT VS TTM AVG
+39.86%
CURRENT VS 3Y AVG
+30.98%
CURRENT VS 5Y AVG
+28.47%
CURRENT VS 10Y AVG
+64.29%
CURRENT VS 15Y AVG
+103.40%
CURRENT VS 20Y AVG
+144.48%
Cigna Corporation
Market Cap
$73.05B
Earnings Per Share (EPS)
24.16
TTM Avg
17.27
3Y Avg
18.45
5Y Avg
18.81
Market Cap
$66.96B
Earnings Per Share (EPS)
2.46
TTM Avg
1.61
3Y Avg
1.19
5Y Avg
0.89
Market Cap
$83.84B
Earnings Per Share (EPS)
40.43
TTM Avg
41.98
3Y Avg
40.38
5Y Avg
45.10
Market Cap
$86.96B
Earnings Per Share (EPS)
29.87
TTM Avg
25.45
3Y Avg
22.39
5Y Avg
20.36
Market Cap
$87.30B
Earnings Per Share (EPS)
22.50
TTM Avg
25.49
3Y Avg
25.23
5Y Avg
24.07
Market Cap
$56.44B
Earnings Per Share (EPS)
7.23
TTM Avg
6.88
3Y Avg
4.62
5Y Avg
2.87
Market Cap
$56.26B
Earnings Per Share (EPS)
-7.98
TTM Avg
-8.27
3Y Avg
-1.90
5Y Avg
3.46
Market Cap
$50.06B
Earnings Per Share (EPS)
1.74
TTM Avg
4.41
3Y Avg
3.40
5Y Avg
2.89
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cigna Corporation (CI) | $73.05B | 24.16 | 17.27 | 18.45 | 18.81 |
| Boston Scientific Corporation (BSX)vs › | $66.96B | 2.46 | 1.61 | 1.19 | 0.89 |
| Cencora, Inc. (COR)vs › | $63.60B | 13.46 | 7.81 | 8.10 | 3.88 |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $83.84B | 40.43 | 41.98 | 40.38 | 45.10 |
| HCA Healthcare, Inc. (HCA)vs › | $86.96B | 29.87 | 25.45 | 22.39 | 20.36 |
| Elevance Health Inc. (ELV)vs › | $87.30B | 22.50 | 25.49 | 25.23 | 24.07 |
| Cardinal Health, Inc. (CAH)vs › | $56.44B | 7.23 | 6.88 | 4.62 | 2.87 |
| Moderna, Inc. (MRNA)vs › | $56.26B | -7.98 | -8.27 | -1.90 | 3.46 |
| Edwards Lifesciences Corporation (EW)vs › | $50.06B | 1.74 | 4.41 | 3.40 | 2.89 |
| Becton, Dickinson and Company (BDX)vs › | $49.54B | 3.32 | 5.86 | 5.65 | 5.38 |
Trailing EPS (TTM)
$24.16
Forward EPS (Est.)
$30.50
P/E Ratio
11.7
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 22.30 |
| 2024-12-31 | 12.25 |
| 2023-12-31 | 17.57 |
| 2022-12-31 | 21.66 |
| 2021-12-31 | 15.89 |
| 2020-12-31 | 23.17 |
| 2019-12-31 | 13.58 |
| 2018-12-31 | 10.69 |
| 2017-12-31 | 9.17 |
| 2016-12-31 | 7.31 |
| 2015-12-31 | 8.17 |
| 2014-12-31 | 7.97 |
| 2013-12-31 | 5.28 |
| 2012-12-31 | 5.70 |
| 2011-12-31 | 4.65 |
| 2010-12-31 | 4.69 |
| 2009-12-31 | 4.75 |
| 2008-12-31 | 1.05 |
| 2007-12-31 | 3.94 |
| 2006-12-31 | 3.49 |
| 2005-12-31 | 4.25 |
| 2004-12-31 | 3.51 |
| 2003-12-31 | 1.51 |
| 2002-12-31 | -1.06 |
| 2001-12-31 | 2.08 |
| 2000-12-31 | 1.96 |
| 1999-12-31 | 3.04 |
| 1998-12-31 | 2.04 |
| 1997-12-31 | 1.64 |
| 1996-12-31 | 1.54 |
Reported annual fiscal-period values; no daily interpolation.
